Survival benefit for patients with advanced-stage transitional cell carcinomas vs. other subtypes of ovarian carcinoma after chemotherapy with platinum and paclitaxel
- 1 April 2005
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 97 (1) , 195-199
- https://doi.org/10.1016/j.ygyno.2004.12.047
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Transitional Cell Carcinoma of the OvaryThe American Journal of Surgical Pathology, 2004
- A Randomized Clinical Trial of Cisplatin/Paclitaxel Versus Carboplatin/Paclitaxel as First-Line Treatment of Ovarian CancerJNCI Journal of the National Cancer Institute, 2003
- Transitional cell carcinomas of the ovary and bladder are immunophenotypically differentHistopathology, 2000
- Clinicopathologic Significance of Transitional Cell Carcinoma Pattern in Nonlocalized Ovarian Epithelial Tumors (Stages 2–4)American Journal of Clinical Pathology, 1998
- Advanced stage transitional cell carcinoma of the ovaryHuman Pathology, 1996
- Transitional Cell Neoplasms of the Ovary and Urinary Bladder: A Comparative Immunohistochemical AnalysisInternational Journal of Gynecological Pathology, 1996
- Transitional cell carcinoma of the ovary: A matched control study of advanced-stage patients treated with cisplatin-based chemotherapyAmerican Journal of Obstetrics and Gynecology, 1993
- Ovarian Carcinomas with Transitional Cell Carcinoma PatterAmerican Journal of Clinical Pathology, 1990
- Transitional cell carcinoma in high-grade high-stage ovarian carcinoma. An indicator of favorable response to chemotherapyCancer, 1989
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958